| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:27267904; PMID:33617914 |
| GO:0000423 | Mitophagy | Increases phenotype | PMID:31100276 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:30439503 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:29154782 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:26757727 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:26757727; PMID:27267904 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:26757727; PMID:27267904; PMID:31566301 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:33617914 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:26757727; PMID:27267904 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:25385720; PMID:27267904; PMID:33617914 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:30439503 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:31100276; PMID:33617914 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:29154782 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:31566301 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:25385720; PMID:26757727; PMID:35503735 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:29154782 |
| GO:0008923 | Lysine decarboxylase activity | Decreases phenotype | PMID:25264276 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25199799 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:26757727; PMID:27267904; PMID:31566301 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:33969458 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:11032765 |
| GO:0031175 | Neuron projection development | Decreases phenotype | PMID:33617914; PMID:33969458 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:26794138 |
| GO:0035265 | Organ growth | Decreases phenotype | PMID:28321044 |
| GO:0035702 | Monocyte homeostasis | Affects phenotype | PMID:29154782 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:27267904 |
| GO:0035937 | Estrogen secretion | Increases phenotype | PMID:30439503 |
| GO:0042701 | Progesterone secretion | Decreases phenotype | PMID:30439503 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:11032765 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:27267904; PMID:32234386; PMID:33617914; PMID:33969458 |
| GO:0044295 | Axonal growth cone | Decreases phenotype | PMID:38653376 |
| GO:0048675 | Axon extension | Decreases phenotype | PMID:31100276 |
| GO:0048709 | Oligodendrocyte differentiation | Decreases phenotype | PMID:33969458 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:31566301 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:31100276; PMID:33617914 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30056177 |
| GO:0060545 | Positive regulation of necroptotic process | Increases phenotype | PMID:38653376 |
| GO:0060711 | Labyrinthine layer development | Decreases phenotype | PMID:31566301 |
| GO:0060712 | Spongiotrophoblast layer development | Decreases phenotype | PMID:31566301 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:33617914 |
| GO:0072655 | Establishment of protein localization to mitochondrion | Affects phenotype | PMID:31100276 |
| GO:1903008 | Organelle disassembly | Increases phenotype | PMID:25385720 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:31100276 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:25199799 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:29154782 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:26794138 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.